These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33941808)

  • 1. Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
    Forbes JM; Le Bagge S; Righi S; Fotheringham AK; Gallo LA; McCarthy DA; Leung S; Baskerville T; Nisbett J; Morton A; Teasdale S; D'Silva N; Barrett H; Jones T; Couper J; Donaghue K; Isbel N; Johnson DW; Donnellan L; Deo P; Akison LK; Moritz KM; O'Moore-Sullivan T
    Sci Rep; 2021 May; 11(1):9422. PubMed ID: 33941808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
    van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
    BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.
    Forbes JM; McCarthy DA; Kassianos AJ; Baskerville T; Fotheringham AK; Giuliani KTK; Grivei A; Murphy AJ; Flynn MC; Sullivan MA; Chandrashekar P; Whiddett R; Radford KJ; Flemming N; Beard SS; D'Silva N; Nisbet J; Morton A; Teasdale S; Russell A; Isbel N; Jones T; Couper J; Healy H; Harris M; Donaghue K; Johnson DW; Cotterill A; Barrett HL; O'Moore-Sullivan T
    Diabetes; 2021 Aug; 70(8):1754-1766. PubMed ID: 34285121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
    Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
    Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
    Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes.
    Jankowska M; Szadkowska A; Pietrzak I; Chrzanowski J; Sołek J; Fendler W; Mianowska B
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
    Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
    Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: A prospective cohort study from the Hong Kong diabetes biobank.
    Jin Q; Lau ES; Luk AO; Ozaki R; Chow EY; So T; Yeung T; Loo KM; Lim CK; Kong AP; ; So WY; Jenkins AJ; Chan JC; Ma RC
    Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):436-446. PubMed ID: 34895800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
    Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
    Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Skin Autofluorescence Levels With Kidney Function Decline in Patients With Peripheral Artery Disease.
    Schutte E; de Vos LC; Lutgers HL; Lambers Heerspink HJ; Wolffenbuttel BH; Vart P; Zeebregts CJ; Gansevoort RT; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1709-14. PubMed ID: 27365407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
    Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
    Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3.
    McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2356-63. PubMed ID: 21885790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
    Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
    J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D
    Chen J; van der Duin D; Campos-Obando N; Ikram MA; Nijsten TEC; Uitterlinden AG; Zillikens MC
    Eur J Epidemiol; 2019 Jan; 34(1):67-77. PubMed ID: 30255328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
    Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
    Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations.
    Rojubally S; Simoneau A; Monlun M; Foussard N; Blanco L; Domenge F; Mohammedi K; Ducasse E; Caradu C; Rigalleau V
    J Diabetes Complications; 2021 Mar; 35(3):107808. PubMed ID: 33386214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
    Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
    PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.